OraSure Technologies to Present at the Piper Jaffray 31st Annual Healthcare Conference
26 11월 2019 - 8:00PM
OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in
point-of-care diagnostic tests and specimen collection devices,
today announced that Dr. Stephen S. Tang, President and CEO, will
speak to the investment community at the Piper Jaffray 31st Annual
Healthcare Conference. The conference will be simultaneously
webcast over the Internet.
Dr. Tang is scheduled to speak on Wednesday,
December 4, 2019, at approximately 12:10 PM Eastern Time (9:10 AM
Pacific Time). Interested investors can access the live webcast of
the presentation by going to OraSure Technologies’ web site,
www.orasure.com and clicking on the Investors link. A replay of the
webcast will be available on OraSure Technologies’ web site for
seven days. Alternatively, you can access the live webcast of the
presentation via the following link:
https://event.webcasts.com/starthere.jsp?ei=1273813&tp_key=c8662f7231.
About OraSure
Technologies
OraSure Technologies is empowering the global
community to improve health and wellness by providing access to
accurate essential information. OraSure is a leader in the
development, manufacture and distribution of point-of-care
diagnostic tests, molecular collection devices and other
technologies designed to detect or diagnose critical medical
conditions. Its first-to-market, innovative products include rapid
tests for the detection of antibodies to HIV and Hepatitis C (HCV)
on the OraQuick® platform, sample self-collection and stabilization
products for molecular applications, and oral fluid laboratory
tests for detecting various drugs of abuse. Together with its
wholly-owned subsidiaries (DNA Genotek, CoreBiome, Diversigen and
Novosanis), OraSure provides its customers with value-added,
end-to-end solutions that encompass tools, diagnostics and
services. OraSure’s portfolio of products is sold globally to
various clinical laboratories, hospitals, clinics, community-based
organizations and other public health organizations, research
institutions, distributors, government agencies, physicians’
offices, commercial and industrial entities and consumers. For more
information on OraSure Technologies, please visit
www.orasure.com.
Company contact:
Roberto Cuca |
Jeanne Mell |
Chief Financial Officer |
VP Corporate Communications |
610-882-1820 |
484-353-1575 |
Investorinfo@orasure.com |
media@orasure.com |
www.orasure.com |
www.orasure.com |
OraSure Technologies (NASDAQ:OSUR)
과거 데이터 주식 차트
부터 6월(6) 2024 으로 7월(7) 2024
OraSure Technologies (NASDAQ:OSUR)
과거 데이터 주식 차트
부터 7월(7) 2023 으로 7월(7) 2024